Evaluating the potential of sNfL as a biomarker in MS management in the UK: insights from SUNLIT survey
Abstract Background Current evidence supports the use of NfL as a biomarker for neuroaxonal damage in multiple sclerosis (MS), but translation from clinical trials to clinical practice is needed to guide optimal patient management. Methods The SUNLIT survey, led by the Novartis medical science liais...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-12-01
|
| Colecção: | BMC Neurology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12883-025-04547-0 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|